Cargando…

Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response

AIMS: This study aimed to identify the plasma metabolite fingerprint in patients with heart failure and to develop a prediction tool based on differential metabolites for predicting the response to cardiac resynchronization therapy (CRT). METHODS AND RESULTS: We prospectively recruited 32 healthy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shengwen, Hu, Yiran, Zhao, Junhan, Jing, Ran, Wang, Jing, Gu, Min, Niu, Hongxia, Chen, Liang, Hua, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835628/ https://www.ncbi.nlm.nih.gov/pubmed/33211407 http://dx.doi.org/10.1002/ehf2.13037

Ejemplares similares

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score
por: Yang, Shengwen, et al.
Publicado: (2020)

A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy
por: Cai, Minsi, et al.
Publicado: (2020)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

A Predictive Model for Super-Response to Cardiac Resynchronization Therapy: The QQ-LAE Score
por: Liu, Xi, et al.
Publicado: (2020)

Prognostic effects of longitudinal changes in left ventricular ejection fraction with cardiac resynchronization therapy
por: Zhang, Nixiao, et al.
Publicado: (2020)

Phosphatidylcholine from krill increases plasma choline and its metabolites in dogs
por: Burri, Lena, et al.
Publicado: (2019)

Predictors of non-response to cardiac resynchronization therapy implantation in patients with class I indications: the markedly dilated left ventricular end-diastolic dimension and the presence of fragmented QRS
por: Hu, Yi-Ran, et al.
Publicado: (2019)

Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response
por: Sultan, A., et al.
Publicado: (2020)

Predictors of positive response to cardiac resynchronization therapy
por: Rinkuniene, Diana, et al.
Publicado: (2014)

Cardiac resynchronization therapy using left ventricular septal pacing: An alternative to biventricular pacing?
por: Gu, Min, et al.
Publicado: (2019)

Circulating metabolite profiles to predict response to cardiac resynchronization therapy
por: Gong, Xue, et al.
Publicado: (2020)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Electrocardiographic Parameters as Predictors of Response to Cardiac Resynchronization Therapy
por: Poposka, Lidija, et al.
Publicado: (2018)

Incidence and predictors of super-response to cardiac resynchronization therapy
por: Rohit, Manoj Kumar, et al.
Publicado: (2019)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

Predictors of super-response to cardiac resynchronization therapy: the significance of heart failure medication, pre-implant left ventricular geometry and high percentage of biventricular pacing
por: Jin, Han, et al.
Publicado: (2017)

Intracellular transport of phosphatidylcholine to the plasma membrane
Publicado: (1985)

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Predictors of Cardiac Resynchronization Therapy Response: The Pivotal Role of Electrocardiogram
por: Al Hebaishi, Yahya S., et al.
Publicado: (2013)

Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy
por: Rocha, Eduardo Arrais, et al.
Publicado: (2015)

The relationship between ECG predictors of cardiac resynchronization therapy benefit
por: Halamek, Josef, et al.
Publicado: (2019)

Length of Hospitalization-Related Differences and Associated Long-Term Prognosis of Patients with Cardiac Resynchronization Therapy: A Propensity Score-Matched Cohort
por: Yu, Yu, et al.
Publicado: (2022)

Septal rebound stretch as predictor of echocardiographic response to cardiac resynchronization therapy
por: Ghani, Abdul, et al.
Publicado: (2015)

Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy
por: Ghossein, Mohammed A, et al.
Publicado: (2022)

Independent and Joint Association of Statin Therapy with Adverse Outcomes in Heart Failure Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy
por: Yu, Yu, et al.
Publicado: (2022)

Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapy
por: Tolosana, Jose María, et al.
Publicado: (2010)

Plasma lipidomics of tuberculosis patients: altered phosphatidylcholine remodeling
por: Wood, Paul L, et al.
Publicado: (2017)

Phosphatidylcholine Biosynthesis in Mitis Group Streptococci via Host Metabolite Scavenging
por: Joyce, Luke R., et al.
Publicado: (2019)

Effectiveness of adding a defibrillator with cardiac resynchronization therapy in heart failure according to the modified Model for End-stage Liver Disease-Albumin score
por: Cheng, Sijing, et al.
Publicado: (2023)

Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing
por: Rath, Benjamin, et al.
Publicado: (2020)

Judgement of the multidisciplinary team is an important predictor of mortality after cardiac resynchronization therapy
por: Passos, Luiz Carlos Santana, et al.
Publicado: (2021)

The Distribution of Phosphatidylcholine Species in Superficial-Type Pharyngeal Carcinoma
por: Ishikawa, Seiji, et al.
Publicado: (2017)

Cardiac Resynchronization Therapy in Children
por: Batra, Anjan S, et al.
Publicado: (2009)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Pediatrics
por: Hill, Allison C., et al.
Publicado: (2018)

Cardiac Resynchronization Therapy Vegetations
por: Hamada, Abdel Haleem Shawky, et al.
Publicado: (2023)

Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapy
por: Behar, Jonathan M., et al.
Publicado: (2017)

Does ‘super-responder’ patients to cardiac resynchronization therapy still have indications for neuro-hormonal antagonists? Evidence from long-term follow-up in a single center
por: Hu, Yi-Ran, et al.
Publicado: (2019)

Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy
por: Foidl, Bettina M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_md54o419t8c87u8db50j0uf27d